Trial Dates Expected for PPI Lawsuits
Trial Dates Expected for PPI Lawsuits
Introduction
On October 11, 2017, Federal Court summoned for a Status Conference for Nexium, Prilosec, and Prevacid Lawsuits. Trial dates are expected soon for this group of proton-pump inhibitors which have 275 lawsuits pending in the multidistrict litigation in the U.S. District Court, District of New Jersey. The main allegation faced by the manufacturers: AstraZeneca Pharmaceuticals LP, Procter & Gamble Co., McKesson Corp., Takeda Pharmaceuticals USA Inc., Novartis Pharmaceuticals Corp., Pfizer Inc., and Pfizer subsidiary Wyeth is that their products caused kidney injuries including acute interstitial nephritis (AIN), chronic kidney disease, and end-stage renal disease.
Comments
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Categories: Opioids
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Categories: Opioids
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…